Tag: Daiichi Sankyo Company Limited

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Daiichi Sankyo Company Limited

LogicBio Therapeutics Announces Research Collaboration with Daiichi Sankyo

Added to Collection on: 2021-04-27 10:52:30

Tags for this article:

Companies
Branches of biology
Gene delivery
Daiichi Sankyo
Biology
Viral vector
Daiichi Sankyo Company Limited
LEXINGTON
LogicBio Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
ENHERTU® (fam-trastuzumab deruxtecan-nxki) significantly improved progression-free survival in ...

Added to Collection on: 2021-08-09 13:07:30

Tags for this article:

Clinical medicine
Cancer treatments
Cancer
Antibody-drug conjugates
Breakthrough therapy
Immunology
Antineoplastic drugs
Trastuzumab emtansine
HER2/neu
Trastuzumab
Breast cancer
Protein kinase inhibitor
T-DM1
Japan
United States
Daiichi Sankyo Company Limited
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
Second Clinical Trial Collaboration Initiated to Evaluate Datopotamab Deruxtecan in ...

Added to Collection on: 2021-10-26 05:53:38

Tags for this article:

Cancer treatments
Clinical medicine
Medicine
Antineoplastic drugs
Cancer immunotherapy
Breakthrough therapy
Orphan drugs
Lung cancer
Pembrolizumab
Non-small-cell lung carcinoma
Daiichi Sankyo
Checkpoint inhibitor
Merck & Co Inc
Daiichi Sankyo Company Limited
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
DESTINY-Lung04 Phase 3 Trial of ENHERTU® Initiated in Patients with Previously ...

Added to Collection on: 2021-12-24 10:36:27

Tags for this article:

Clinical medicine
Cancer treatments
Medicine
Antineoplastic drugs
Breakthrough therapy
Immunology
Antibody-drug conjugates
HER2/neu
Trastuzumab
Pembrolizumab
Targeted therapy
Non-small-cell lung carcinoma
Daiichi Sankyo
Daiichi Sankyo Company Limited

Click the tags to see associated articles and topics

View Article Details
Enhertu significantly improved both progression-free and overall survival in DESTINY ...

Added to Collection on: 2022-02-21 07:30:04

Tags for this article:

Clinical medicine
Cancer
Health
Breast cancer
Immunology
Antibody-drug conjugates
Trastuzumab
HER2/neu
Breast cancer management
Triple-negative breast cancer
Trastuzumab emtansine
Antibody-drug conjugate
Daiichi Sankyo
Daiichi Sankyo Company Limited
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US for ... - BioSpace

Added to Collection on: 2022-04-19 11:46:29

Tags for this article:

Clinical medicine
Drugs
Health
Breakthrough therapy
Orphan drugs
Antibody-drug conjugates
Cancer treatments
Morpholines
HER2/neu
Trastuzumab deruxtecan
Gefitinib
Non-small-cell lung carcinoma
Trastuzumab
United States
DAIICHI SANKYO , INC
Daiichi Sankyo Company Limited
AstraZeneca

Click the tags to see associated articles and topics

View Article Details
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Breakthrough Therapy Designation ...

Added to Collection on: 2022-04-27 11:37:02

Tags for this article:

Clinical medicine
Medicine
Health care
Cancer treatments
Breakthrough therapy
Antibody-drug conjugates
Immunology
Specialty drugs
HER2/neu
Trastuzumab
Breast cancer
Adjuvant therapy
United States
DAIICHI SANKYO , INC
Daiichi Sankyo Company Limited
AstraZeneca
ENHERTU ENHERTU

Click the tags to see associated articles and topics

View Article Details
Daiichi Sankyo Company, Limited (DSKYF) CEO Sunao Manabe on Q4 2021 Results

Added to Collection on: 2022-04-30 16:40:18

Tags for this article:

Cancer
Clinical medicine
Medicine
Cancer treatments
HER2/neu
Trastuzumab emtansine
Breast cancer
Triple-negative breast cancer
Daiichi Sankyo
Non-small-cell lung carcinoma
Pertuzumab
US Dollar/Japanese Yen FX Spot Rate, FX Spot Rate, THOMSON REUTERS
Japanese yen
Japan
Mitsubishi UFJ Morgan Stanley Securities
Daiichi Sankyo Company Limited
MORGAN STANLEY SECURITIES
Citigroup
Goldman Sachs Securities
ET Company
United States
Wataru Takasaki Takasaki
US Dollar
Wataru Takasaki

Click the tags to see associated articles and topics

View Article Details